RELAX-AHF-2: Serelaxin in Acute Heart Failure, Part 2.

29 April 2017 (09:29 - 09:30)

Organised by:

About the speaker

Professor Marco Metra

IRCCS San Raffaele Scientific Institute, Milan (Italy)

10 More presentations in this session

Presentation thumbnail

Bromocriptine for the treatment of peripartum cardiomyopathy - Multicenter proof of concept study.

Professor D. Hilfiker-Kleiner (Hannover, DE)

Presentation thumbnail

Bromocriptine for the treatment of peripartum cardiomyopathy - Multicenter proof of concept study - Discussion.

Presentation thumbnail

Safety and efficacy of low dose intracoronary insulin-like growth factor 1 to prevent heart failure following percutaneous coronary intervention for acute myocardial infarction (RESUS-AMI).

Professor N. Caplice (Cork, IE)

Presentation thumbnail

Discussion: RESUS-AMI.

Presentation thumbnail

Relationship between baseline systolic blood pressure and long term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Doctor G. cotter (Durham, US)

Access the full session

Session thumbnail

Late Breaking Trials I: Focus on acute heart failure

The Event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 09:29 CET

You may be interested in

Congress Session

Management of acute heart failure: therapeutic approaches and prognosis

18 May 2025

Congress Presentation

Safety, pharmacokinetics, and pharmacodynamics of AZD3427, a functionally selective long acting relaxin mimetic agonist of the RXFP1 receptor

20 May 2023

Congress Presentation

RELAXIN-LA in worsening HFpEF

31 August 2025

Webinar

GLP-1 RAs and HFpEF: which HFpEF patients should now be receiving GLP-1 RAs?

15 December 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources